Pathophysiology of MS and mechanism of action of natalizumab. | Download Scientific Diagram
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project - The Lancet Oncology
Figure 1 | The Role of Alpha-4 Integrin in the Aetiology of Multiple Sclerosis | SpringerLink
Figure 3 from Predictors of Response to Multiple Sclerosis Therapeutics in Individual Patients | Semantic Scholar
Brain Sciences | Free Full-Text | Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab
References in Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines - Multiple Sclerosis and Related Disorders
Currently Approved Disease-Modifying Drugs: Monoclonal Antibody Natalizumab - ScienceDirect
Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns - ScienceDirect
Frontiers | Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies | Immunology
Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences
Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML
Natalizumab - Wikipedia
A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine
The use of immune modulating drugs for the treatment of multiple sclerosis | Neurosciences Journal
Multiple Sclerosis: Mechanisms and Immunotherapy - ScienceDirect
Multiple Sclerosis: Mechanisms and Immunotherapy - ScienceDirect
Natalizumab for Multiple Sclerosis | NEJM
Natalizumab and glatiramer acetate mechanism of action. A. Natalizumab... | Download Scientific Diagram
Natalizumab (Tysabri) | American Journal of Neuroradiology
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities
Potential mechanisms of action related to the efficacy and safety of cladribine - Multiple Sclerosis and Related Disorders
Simplified overview of postulated mechanism of action of standard... | Download Scientific Diagram
Identification and development of new therapeutics for multiple sclerosis: Trends in Pharmacological Sciences
Frontiers | Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies | Immunology
Multiple sclerosis and drug discovery: A work of translation - eBioMedicine
